Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis

Oncogene

Volumn 19, Issue 7, 2000, Pages 889-898

  Hadsell, Darryl L ^a   Murphy, Kristen L ^a   Bonnette, Sharon G ^a   Reece, Naomi ^a   Laucirica, Rodolfo ^a   Rosen, Jeffrey M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; IGF I; Mutant p53; Transgenic mouse model; Tumorigenesis

Indexed keywords

MUTANT PROTEIN; PROTEIN P53; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ANEUPLOIDY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; BREAST CARCINOGENESIS; CANCER INCIDENCE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0034677588     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203386     Document Type: Article

References (48)

1. Aas T, Borresen AL, Geisler S, Smith-Sorensen B, Johnsen H, Varhaug JE, Akslen LA and Lonning PE. (1996). Nature Med., 2, 811-814.
2. Amundadottir LT, Nass SJ, Berchem GJ, Johnson MD and Dickson RB. (1996). Oncogens, 13, 757-765.
3. Arteaga CL. (1992). Br. Cancer Res. Treat., 22, 101-106.
4. Bates P, Fisher R, Ward A, Richardson L, Hill DJ and Graham CF. (1996). Br. J. Cancer, 72, 1189-1193.
5. Ben-David Y and Berstein A. (1991). Cell. 66, 831-834.
6. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR and Kley N. (1995). Nature, 377, 646-649.
7. Cardiff RD, Anver MR, Gusterson BA, Henninghausen L, Jensen RA, Merino MJ, Rehn S, Russo J, Tavbassoli FA, Wakefield LM, Ward JM and Green JE. (2000). Oncogene, in press.
8. Christofori G, Naik P and Hanahan D. (1994). Nature, 369, 414-418.
9. Conover CA and Bale LK. (1992). Endocrinology, 131, 608-614.
10. Conover CA and Powell DR. (1991). Endocrinology, 129, 710-716.
11. Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME and Rosen N. (1990). Cancer Res., 50, 48-53.
12. Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M, Finlay C and Levine AJ. (1993). Nature Genetics, 4, 42-46.
13. Dunn T. (1959). Physiopathology of Cancer. Homburger F. (ed.) A.J. Phiebig: New York. pp 38-83.
14. Fukasawa K, Choi T, Kuriyama R, Rulong S and Vande Woude GF. (1996). Science, 271, 1744-1747.
15. Gai XX, Rizzo MG, Lee J, Ullrich A and Baserga R. (1988). Oncogene Res., 3, 377-386.
16. Gill ZP, Perks CM, Newcomb PV and Holly JMP. (1997). J. Biol. Chem., 272, 25602-25607.
17. Gualberto A, Aldape K, Kozakiewics K and Tlsty TD. (1998). Proc. Natl. Acad. Sci. (USA), 95, 5166-5171.
18. Hachiya M, Chumakov A, Miller CW, Akashi M, Said J and Koeffler HP. (1994). Anticancer Res., 14, 1853-1860.
19. Hadsell DL, Greenberg NM, Fligger JM, Baumrucker CR and Rosen JM. (1996). Endocrinology, 137, 321-330.
20. Hainaut P, Soussi T, Shomer B, Hollstein M, Greenblatt M, Hovig E, Harris CC and Montesano R. (1997). Nucleic Acids Res., 25, 151-157.
21. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science. 253, 49-53.
22. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW and Vogelstein B. (1992). Science. 256, 827-830.
23. Kleinberg DI. (1997). J. Mamm. Gland Biol. Neoplas., 2, 49-57.
24. Li B, Murphy KL, Laucirica R, Kittrell F, Medina D and Rosen JM. (1998). Oncogene, 16, 997-1007.
25. Li B, Rosen JM, McMenamin-Balano J, Muller WJ and Perkins AS. (1997). Mol. Cell Biol., 17, 3155-3163.
26. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T and Tlsiy TD. (1992). Cell, 70, 923-935.
27. Murphy KL and Rosen JM. (2000). Oncogene, in press.
28. Morgan WF, Corcoran J, Hartmann A, Kaplan MI, Limoli CL and Ponnaiya B. (1998). Mutat. Res., 404, 125-128.
29. Neiman PE, Bush C, Heydt C, Loring G and Thomas SJ. (1994). Mol. Biol. Cell, 5, 763-772.
30. Neuenschwander S, Schwartz A, Wood TL, Roberts Jr CT, Hennighausen L and Leroith D. (1996). J. Clin. Invest., 97, 2225-2232.
31. Ohlsson C, Kley N, Werner H and LeRoith D. (1998). Endocrinology, 139, 1101-1107.
32. Ory K, Legros V, Auguin C and Soussi T. (1994). EMBO J., 13, 3496-3504.
33. Pravtcheva DD and Wise TL. (1999). J. Exp. Zool., 281, 43-57.
34. Quarrie LH, Addey CV and Wilde CJ. (1996). J. Cell Physiol., 168, 559-569.
35. Schuller AGP, Groffen C, van Neck JW and Drop SLS. (1994). Mol. Cell Endocrinol., 104, 57-66.
36. Sell C, Rubini M, Rubin R, Liu JP, Efstratiadis A and Baserga R. (1993). Proc. Natl. Acad. Sci. USA, 90, 11217-11221.
37. Starbog M, Gell K, Brundell E and Höög C. (1996). J. Cell Sci., 109, 143-153.
38. Strange R, Li F, Saurer S, Burkhardt A and Friis RR. (1992). Development, 115, 49-58.
39. Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Jacks T and Van Dyke T. (1994). Cell, 78, 703-711.
40. Turner BC, Haffty BG, Narayanan L, Yuan J, Havre PA, Gumbs AA, Kaplan L, Burgaud JL, Carter D, Baserga R and Glazer PM. (1997). Cancer Res., 57, 3079-3083.
41. Valentinis B, Bhala A, Deangelis T, Baserga R and Cohen P. (1995). Mol. Endocrinol., 9, 361-367.
42. Villafuerte BC, Zhang WN and Phillips LS. (1996). Mol. Endocrinol., 10, 622-630.
43. Wada J, Liu ZZ, Alvares K, Kumar A, Wallner E, Makino H and Kanwar YS. (1993). Proc. Natl. Acad. Sci. (USA), 90, 10360-10364.
44. Wang XJ, Greenhalgh DA, Jiang A, He D, Zhong L, Medina D, Brinkley BR and Roop DR. (1998). Oncogene, 17, 35-45.
45. Webster NG, Resnik JL, Reichart DB, Strauss B, Haas M and Seely L. (1996). Cancer Res., 56, 2781-2788.
46. Werner H, Karnieli E, Rauscher III FJ, and LeRoith D. (1996). Proc. Natl. Acad. Sci. (USA), 93, 8318-8323.
47. Yee D, Cullen KJ, Paik S, Perdue JF, Hampton B, Schwartz A, Lippman ME and Rosen N. (1988). Cancer Res., 48, 6691-6696.
48. Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, Cullen KJ, Lippman ME and Rosen N. (1989). Mol. Endocrinol., 3, 509-517.